shRNA-Notch1 attenuated the enhancement effect of the inhibitor on EMT and the proliferation, migration, and invasion of glioma cells, thus confirming that miR-30c regulates these processes in glioma cells posttranscriptionally by targeting Notch1. Here, NOTCH1 is linked to central nervous system cancer.